H 4332
An Act relative to pharmacists as healthcare providers
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill expands the role of pharmacists in Massachusetts healthcare by allowing them to order, test, screen, and treat certain health conditions, including influenza, strep infections, and COVID-19, subject to department guidelines and regulations. It establishes procedures for pharmacists to perform these services and ensures reimbursement for these services from health benefit plans, similar to those provided by physicians or other healthcare professionals. The bill also allows for delegation of tasks to pharmacy technicians under pharmacist supervision.
Key provisions
- Pharmacists can order, test, screen, and treat influenza, strep infections, and COVID-19.
- The Department of Public Health will create standard procedures for pharmacists to perform these tests and treatments.
- Pharmacists can use waived laboratory tests for clinical decision-making.
- Pharmacists can delegate administrative and technical tasks to pharmacy technicians.
- Health benefit plans must reimburse pharmacists for services performed within their scope of practice.
- Insurance carriers must develop provider and consult codes for pharmacy compensation.
- The bill applies to emerging and existing public health threats identified by the department.
- The bill allows for the use of Clinical Laboratory Improvement Amendments (CLIA) waived tests.
Who is affected
- Pharmacists
- Patients
- Health Benefit Plans
- Insurance Carriers
- Pharmacy Benefit Managers
Notable changes
Sponsors
Official sponsors from legislative records.
Primary sponsor
Joint Committee on Financial Services
Cosponsor
Christine P. Barber
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.4332 194th (Current)
An Act relative to pharmacists as healthcare providers
View Text Print Preview Download PDF
Bill Information
Bill Information
Sponsor: Joint Committee on Financial Services Status: Referred to Joint Committee on Health Care Financing
Tabs
Bill History Cosponsors Committee Vote Committee Summary
Bill History
Displaying 5 actions for Bill H.4332
| Date | Branch | Action |
| 7/31/2025 | House | Reported from the committee on Financial Services |
| 7/31/2025 | House | New draft of H1091 |
| 7/31/2025 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 12/8/2025 | House | Reporting date extended to Wednesday, March 18, 2026 |
| 3/19/2026 | House | Reporting date extended to Monday, June 15, 2026 |
Similar Bills
H.1091 194th (Current)
An Act relative to pharmacists as healthcare providers
S.800 194th (Current)
An Act relative to pharmacists as healthcare providers
H.4066 193rd (2023 - 2024)
An Act relative to pharmacists as healthcare providers
S.1425 193rd (2023 - 2024)
An Act relative to pharmacists as healthcare providers
H.2041 189th (2015 - 2016)
An Act recognizing pharmacists as healthcare providers
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.